Larvol Delta - Oltipraz-for-Liver-Fat-Reduction-in-Patients-With-Nonalcoholic-Fatty-Liver-Disease-Except-for-Liver-Cirrhosis

oltipraz (PMK-N01GI1) - Canopus BioPharma, Pharmaking

http://clinicaltrials.gov/ct2/show/NCT04142749

Oct 6, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next